
Retatrutide GLP-3
20 mgThe Element ResearchCOAs available · Purity > 98%
Limited stock
Pre-order offer closed as of 3 July — delivery times are back to normal.
New orders: shipped within 48–72 business hours after payment confirmation.
Pre-order customers: you will receive your full shipment during the week ahead. Thank you for your trust.
Free shipping for orders over 200 €. · Products for research only.
Lyophilized research compound
In-vitro research reagent. Not for human or veterinary consumption.
Protect your delivery
Optional at checkout: stuck, damaged or lost parcel — priority reshipment or refund.
Ce produit est destiné exclusivement à la recherche scientifique in vitro et préclinique. Il n'est pas approuvé pour un usage humain ou vétérinaire.
How to reconstitute this vial?
10 mg vial — 4 essential steps, about 3 minutes.
Vial format

Reconstitution solvent
BACT-H2O · 10 ml USP
Total
40 €
Limited stock on GLP-3 RTA 20MG, GHK 50MG, and MT2 10MG: for this SKU, availability may change quickly.
Shipping within 24–48h subject to availability.
At a glance
HPLC purity
>98.64 %
Third-party tested
Presentation
10 mg
Lyophilized research compound
Certificate of analysis
Open PDFShipping
EU · 24–48h
Protective packaging
This lyophilized peptide is intended for in-vitro and preclinical research. It is formulated to provide stability and purity suited to advanced research protocols. Not for direct human or veterinary consumption.
The Element Research peptides are selected for their long-term stability and compatibility with demanding research protocols. Lyophilization ensures optimal storage before reconstitution.
Every catalog reference is checked to the same standards: identity, purity and integrity before dispatch.
Complete your research protocol with these compounds.

20 mgThe Element ResearchCOAs available · Purity > 98%
Limited stock

10 mgThe Element ResearchCOAs available · Purity > 98%

50 mgThe Element ResearchCOAs available · Purity > 98%
Limited stock

10 mgThe Element ResearchCOAs available · Purity > 98%
This site uses technical cookies necessary for its operation. Learn more